3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
25
Lymphoma
15
Neutropenia
9
Lymphoma, Large B-Cell, Diffuse
7
Leukemia
7
Carcinoma, Non-Small-Cell Lung
7
Neoplasms
6
Lymphoma, Follicular
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Triple Negative Breast Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Ovarian Neoplasms
4
Hodgkin Disease
4
Chemotherapy-induced Neutropenia
4
Urinary Bladder Neoplasms
3
Neoplasm Metastasis
3
Multiple Myeloma
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma, B-Cell, Marginal Zone
3
Colorectal Neoplasms
3
Burkitt Lymphoma
3
Breast Neoplasms, Male
3
Adenocarcinoma, Bronchiolo-Alveolar
3
Adenocarcinoma of Lung
3
Waldenstrom Macroglobulinemia
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Sarcoma
2
Interventions
pralsetinib
2
pembrolizumab
2
Brentuximab Vedotin
2
Bevacizumab
2
ribociclib
1
fosaprepitant
1
Sunitinib
1
Sirolimus
1
Radiotherapy, Image-Guided
1
Plicamycin
1
Pemetrexed
1
Paclitaxel
1
Oxaliplatin
1
Genistein
1
Gemcitabine
1
Erlotinib Hydrochloride
1
Dexamethasone
1
Cisplatin
1
Carboplatin
1
Aprepitant
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neoplasms, Germ Cell and Embryonal
×
pegfilgrastim
×
Clear all
No trials found.